U.S. markets closed

Smith & Nephew plc (SNN)

NYSE - NYSE Delayed Price. Currency in USD
25.42-0.38 (-1.47%)
At close: 04:00PM EDT
25.42 0.00 (0.00%)
After hours: 05:28PM EDT
  • Dividend

    SNN announced a cash dividend of 0.288 with an ex-date of Oct. 5, 2023

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close25.80
Bid25.19 x 800
Ask26.03 x 1100
Day's Range25.42 - 25.68
52 Week Range21.78 - 33.09
Avg. Volume771,112
Market Cap11.101B
Beta (5Y Monthly)0.42
PE Ratio (TTM)50.84
EPS (TTM)0.50
Earnings DateN/A
Forward Dividend & Yield0.75 (2.91%)
Ex-Dividend DateOct 05, 2023
1y Target Est34.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
26% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SNN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Smith & Nephew SNATS, Inc.
    Analyst Report: Smith & Nephew plcSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more